Differences

This shows you the differences between two versions of the page.

--- wiki:start:demo [2023/06/07 20:17]
jthurnham [Demo Nests]
+++ wiki:start:demo [2023/06/07 20:22] (current)
jthurnham [Non Small Cell Lung Cancer (NSCLC): Tyrosine kinase inhibitors (TKIs)]
@@ Line 19: / Line 19: @@
   * Our [[:wiki:start:demo:covid19|COVID-19: Antivirals]] nest was [[https://pubmed.ncbi.nlm.nih.gov/35100985/|published]] in BMC Infectious Disease in January 2022. You can use a copy of the nest to practice searching the COVID-19 literature.
-==== Osteoarthritis: Tanezumab ====
+==== Non Small Cell Lung Cancer (NSCLC): Tyrosine kinase inhibitors (TKIs) ====
-  * Our [[:wiki:start:demo:osteoarthritis|Osteoarthritis: Tanezumab]] nest examines the safety and efficacy of different doses of Tanezumab, a therapeutic that recently underwent [[https://www.fda.gov/media/146867/download|FDA scrutiny]] for adverse events in high dose ranges.
+  * Our [[:wiki:start:demo:hta_nsclc|NSCLC: Tyrosine Kinase Inhibitors]] nest examines the treatment of NSCLC with various types of tyrosine kinase inhibitors. This is based on a published [[https://icer.org/assessment/non-small-cell-lung-cancer-2016/ | Institute for Clinical and Economic Review (ICER) review]].
+//This nest is specifically designed to meet the requirements of Health Technology Assessment (HTA) body: [[https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines#:~:text=NICE%20guidelines%20are%20evidence%2Dbased,in%20particular%20circumstances%20or%20settings.|National Institute for Health and Care Excellence (NICE).]]//
 ==== Heart Failure: ACE Inhibitors & ARBs ====

Nested Knowledge

User Tools

Site Tools

Differences

Page Tools